Trastuzumab Biosimilar Market Demand Analysis and Developments in Targeted Oncology Therapies
The Trastuzumab Biosimilar Market is gaining momentum due to the increasing demand for affordable cancer treatments and the growing adoption of biosimilar medicines. Trastuzumab is a monoclonal antibody used primarily in the treatment of HER2-positive breast cancer and certain other HER2-positive cancers. Trastuzumab biosimilars are highly similar versions of the original biologic medicine and...
0 Comments 0 Shares 37 Views 0 Reviews